Atrial fibrillation Trials in Shijiazhuang, China
Conditions / Atrial fibrillation / Shijiazhuang, China
Clinical trials for Atrial fibrillation investigate a range of treatment strategies and patient populations.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04376606 | Changes of Left Atrial Function and Quality of Life After Transcatheter Closure of Left Atrial Appendage in Patients With Atrial Fibrillation | COMPLETED | NA |
| NCT00781391 | Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT05757869 | A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00496769 | A Phase III Study of Apixaban in Patients With Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT00412984 | Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT05643573 | A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke | TERMINATED | PHASE3 |
| NCT03322085 | The Influence of Catheter Ablation for Atrial Fibrillation on Atrial Electrical | COMPLETED | NA |
| NCT00808067 | RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial | COMPLETED | PHASE3 |
| NCT01468701 | GLORIA-AF Registry Program - Second and Third Phases | COMPLETED | — |
| NCT00262600 | Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate | COMPLETED | PHASE3 |